CClinicalTrials.gg
CompletedNCT03330496iPAS)Updated Jun 8, 2022

Assessment of Pain in Newborns and Older Infants (Infant Pain Assessment Study =

An observational study in Pain, Acute, sponsored by Stanford University. Completed at 1 site in United States. Open to participants aged 1 Day to 6 Months. Per ClinicalTrials.gov, last updated 2022-06-08.

Sponsored by Stanford University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
43
Ages
1 Day to 6 Months
Sex
All
01

Study summary

Pain assessments in non-verbal, critically ill infants represent an important clinical challenge. Older children or adults can easily express their pain, but infants lack that capability. They frequently experience repetitive acute pain during routine ICU care, but their analgesic management flounders on the horns of a dilemma: (a) failure to treat infant pain leads to immediate clinical instability and potentially long-term physical, behavioral, and cognitive sequelae, vs. (b) strong analgesics may increase risks for medical complications and/or impaired brain growth. Bedside nurses currently assess pain using pain scores, before taking action to ameliorate pain. Pain scores increase nursing workload and provide subjective assessments, rather than objective data for evaluating infant pain. Consequently, infants exposed to skin-breaking procedures, surgery, or other painful conditions often receive variable and inconsistent pain management in the ICU. The investigators aim to develop a multimodal pain assessment system, using sensor fusion and novel machine learning algorithms to provide an objective measure of pain that is context-dependent and rater-independent. This will enhance the quality of pain management in ICUs and allow continuous pain monitoring in real-time.

02

Conditions studied

  • Pain, Acute

Browse trials for

Keywords

  • infant-newborn
  • infant-premature
  • pain
  • acute pain
03

Who can participate

Ages eligible
1 Day to 6 Months
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

We will collect data from 30 study subjects in each of the following age groups:

  • Preterm infants (34-37 weeks, postnatal age 3-30 days)
  • Term newborns (37-42 weeks gestation, less than 1 month of age)
  • Infants from 1-3 months age, and
  • Older infants from 3-6 months age. A total of 120 subjects will be recruited before study closure.

Inclusion criteria

    1. All infants less than 6 months of corrected chronological age. 2. Infants admitted to the participating ICUs at LPCH (NICU, PICU, CVICU). 3. Require an acute painful procedure for routine clinical care.

Exclusion criteria

Exclusion Criteria:

  1. Newborns with birth trauma, intrapartum asphyxia (5-minute Apgar Score \<4 or cord pH \< 7.01), fetal growth restriction (birth weight \< 5th percentile for gestation), congenital anomalies or metabolic disorders, or any kind of brain injury.
  2. Newborns born to mothers with a history of heavy smoking or drug abuse (alcohol, cocaine, ketamine, heroin/other opiates) or psychiatric drugs used during this pregnancy.
  3. Newborns and infants requiring positive pressure ventilation using a face mask (BiPAP) or endotracheal tube (conventional or high-frequency ventilators).
  4. Newborns and infants receiving continuous infusions of opioid drugs (morphine, fentanyl, others) and nerve blocks or neuraxial analgesia affecting the site of the invasive procedure during the 24 hours prior to study entry. (Note: Infants receiving intermittent opioids or non-opioid analgesics (acetaminophen, ibuprofen, ketorolac, others) WILL NOT be excluded).
  5. Newborns and infants with facial anomalies, injuries or other pathologies affecting the facial area.
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
43 participants (actual)
Patient registry
No

Groups and cohorts

  • Preterm infants

    preterm neonates (34-37 weeks gestational age, n=15)

    Other: Pain Measurement

  • Term infants

    term newborns (37-42 weeks gestation, n=15)

    Other: Pain Measurement

  • Small infants

    1-3 month-old infants (n=15)

    Other: Pain Measurement

  • Older infants

    3-6 month-old infants (n=15)

    Other: Pain Measurement

Interventions

  • OtherPain Measurement

    Measurement of infant responses (behavioral and physiological) during a painful procedure.

05

What researchers measure

Primary outcomes

  1. Pain Measurement (all infants)

    Visual Analogue Scale (VAS) measures pain intensity based on observer assessment on a scale from 1 to 10, where higher values indicate more intense pain.

    Time frame: 10 minutes

Secondary outcomes

  1. Pain Measurement

    Facial Expressions specific for infant pain will be assessed, including nasolabial furrow and brow bulge. Presence or absence as well as the duration for each facial expression will be recorded during the painful procedure. These facial expressions were chosen from the Neonatal Facial Coding Scale (NFCS) and the Premature Infant Pain Profile (PIPP).

    Time frame: 30 minutes

  2. Pain Measurement (newborns 0-30 days)

    Neonatal Pain, Agitation and Sedation Scale (N-PASS) measures level of sedation versus increasing pain or agitation in newborns. Scores range from -10 to +10, where negative scores denote increasing levels of sedation, zero indicates a neutral condition, and positive scores indicate increasing pain intensity and/or agitation.

    Time frame: 5 minutes

  3. Pain Measurement (newborns 0-30 days)

    Premature Infant Pain Profile - Revised (PIPP-R) measures pain intensity in newborns, with scores ranging from 0 to 21, higher scores indicating greater pain (adjusted for prematurity and behavioral state).

    Time frame: 8 minutes

  4. Pain Measurement (infants 1-6 months)

    Face, Legs, Activity, Cry, Consolability scale (FLACC scale) measures pain in children between the ages of 2 months and 7 years. The scale is scored in a range of 0-10 with 0 representing no pain and 10 indicating severe pain.

    Time frame: 3 minutes

06

Study locations

1 site
  • Lucile Packard Children's Hospital Stanford
    Palo Alto, California 94304, United States
07

References and documents

Publications

  • Roue JM, Morag I, Haddad WM, Gholami B, Anand KJS. Using sensor-fusion and machine-learning algorithms to assess acute pain in non-verbal infants: a study protocol. BMJ Open. 2021 Jan 6;11(1):e039292. doi: 10.1136/bmjopen-2020-039292. PubMed 33408199 ↗

Individual participant data

Plan to share: No — No data will be shared

08

Registry details

Key details

Study ID
NCT03330496
Lead sponsor
Stanford University
Collaborators
Autonomous Healthcare, Inc.
Responsible party
Kanwaljeet Anand (Professor of Pediatrics, Anesthesiology, Perioperative & Pain Medicine, Stanford University) — Principal investigator
First posted
Nov 6, 2017
Start date
Oct 30, 2017
Primary completion
Apr 29, 2021
Completion
Mar 30, 2022
Last update
Jun 8, 2022

Study contacts

Kanwaljeet S Anand, MBBS, D.Phil.
principal investigator · Prof.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion